Cargando…
Development of a life expectancy table for individuals with type 1 diabetes
AIMS/HYPOTHESIS: Tables reporting life expectancies by common risk factors are available for individuals with type 2 diabetes; however, there is currently no published equivalent for individuals with type 1 diabetes. We aimed to develop a life expectancy table using a recently published simulation m...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310903/ https://www.ncbi.nlm.nih.gov/pubmed/34309688 http://dx.doi.org/10.1007/s00125-021-05503-6 |
_version_ | 1783728848739762176 |
---|---|
author | Tran-Duy, An Knight, Josh Clarke, Philip M. Svensson, Ann-Marie Eliasson, Björn Palmer, Andrew J. |
author_facet | Tran-Duy, An Knight, Josh Clarke, Philip M. Svensson, Ann-Marie Eliasson, Björn Palmer, Andrew J. |
author_sort | Tran-Duy, An |
collection | PubMed |
description | AIMS/HYPOTHESIS: Tables reporting life expectancies by common risk factors are available for individuals with type 2 diabetes; however, there is currently no published equivalent for individuals with type 1 diabetes. We aimed to develop a life expectancy table using a recently published simulation model for individuals with type 1 diabetes. METHODS: The simulation model was developed using data from a real-world population of patients with type 1 diabetes selected from the Swedish National Diabetes Register. The following six important risk factors were included in the life table: sex; age; current smoking status; BMI; eGFR; and HbA(1c). For each of 1024 cells in the life expectancy table, a synthetic cohort containing 1000 individuals was created, with other risk factors assigned values representative of the real-world population. The simulations were executed for all synthetic cohorts and life expectancy for each cell was calculated as mean survival time of the individuals in the respective cohort. RESULTS: There was a substantial variation in life expectancy across patients with different risk factor levels. Life expectancy of 20-year-old men varied from 29.3 years to 50.6 years, constituting a gap of 21.3 years between those with worst and best risk factor levels. In 20-year-old women, this gap was 18.9 years (life expectancy range 35.0–53.9 years). The variation in life expectancy was a function of the combination of risk factor values, with HbA(1c) and eGFR consistently showing a negative and positive correlation, respectively, with life expectancy at any level combination of other risk factors. Individuals with the lowest level (20 kg/m(2)) and highest level of BMI (35 kg/m(2)) had a lower life expectancy compared with those with a BMI of 25 kg/m(2). Non-smokers and women had a higher life expectancy than smokers and men, respectively, with the difference in life expectancy ranging from 0.4 years to 2.7 years between non-smokers and smokers, and from 1.9 years to 5.9 years between women and men, depending on levels of other risk factors. CONCLUSIONS/INTERPRETATION: The life expectancy table generated in this study shows a substantial variation in life expectancy across individuals with different modifiable risk factors. The table allows for rapid communications of risk in an easily understood format between healthcare professionals, health economists, researchers, policy makers and patients. Particularly, it supports clinicians in their discussion with patients about the benefits of improving risk factors. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-021-05503-6. |
format | Online Article Text |
id | pubmed-8310903 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-83109032021-07-26 Development of a life expectancy table for individuals with type 1 diabetes Tran-Duy, An Knight, Josh Clarke, Philip M. Svensson, Ann-Marie Eliasson, Björn Palmer, Andrew J. Diabetologia Article AIMS/HYPOTHESIS: Tables reporting life expectancies by common risk factors are available for individuals with type 2 diabetes; however, there is currently no published equivalent for individuals with type 1 diabetes. We aimed to develop a life expectancy table using a recently published simulation model for individuals with type 1 diabetes. METHODS: The simulation model was developed using data from a real-world population of patients with type 1 diabetes selected from the Swedish National Diabetes Register. The following six important risk factors were included in the life table: sex; age; current smoking status; BMI; eGFR; and HbA(1c). For each of 1024 cells in the life expectancy table, a synthetic cohort containing 1000 individuals was created, with other risk factors assigned values representative of the real-world population. The simulations were executed for all synthetic cohorts and life expectancy for each cell was calculated as mean survival time of the individuals in the respective cohort. RESULTS: There was a substantial variation in life expectancy across patients with different risk factor levels. Life expectancy of 20-year-old men varied from 29.3 years to 50.6 years, constituting a gap of 21.3 years between those with worst and best risk factor levels. In 20-year-old women, this gap was 18.9 years (life expectancy range 35.0–53.9 years). The variation in life expectancy was a function of the combination of risk factor values, with HbA(1c) and eGFR consistently showing a negative and positive correlation, respectively, with life expectancy at any level combination of other risk factors. Individuals with the lowest level (20 kg/m(2)) and highest level of BMI (35 kg/m(2)) had a lower life expectancy compared with those with a BMI of 25 kg/m(2). Non-smokers and women had a higher life expectancy than smokers and men, respectively, with the difference in life expectancy ranging from 0.4 years to 2.7 years between non-smokers and smokers, and from 1.9 years to 5.9 years between women and men, depending on levels of other risk factors. CONCLUSIONS/INTERPRETATION: The life expectancy table generated in this study shows a substantial variation in life expectancy across individuals with different modifiable risk factors. The table allows for rapid communications of risk in an easily understood format between healthcare professionals, health economists, researchers, policy makers and patients. Particularly, it supports clinicians in their discussion with patients about the benefits of improving risk factors. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-021-05503-6. Springer Berlin Heidelberg 2021-07-26 2021 /pmc/articles/PMC8310903/ /pubmed/34309688 http://dx.doi.org/10.1007/s00125-021-05503-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Tran-Duy, An Knight, Josh Clarke, Philip M. Svensson, Ann-Marie Eliasson, Björn Palmer, Andrew J. Development of a life expectancy table for individuals with type 1 diabetes |
title | Development of a life expectancy table for individuals with type 1 diabetes |
title_full | Development of a life expectancy table for individuals with type 1 diabetes |
title_fullStr | Development of a life expectancy table for individuals with type 1 diabetes |
title_full_unstemmed | Development of a life expectancy table for individuals with type 1 diabetes |
title_short | Development of a life expectancy table for individuals with type 1 diabetes |
title_sort | development of a life expectancy table for individuals with type 1 diabetes |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310903/ https://www.ncbi.nlm.nih.gov/pubmed/34309688 http://dx.doi.org/10.1007/s00125-021-05503-6 |
work_keys_str_mv | AT tranduyan developmentofalifeexpectancytableforindividualswithtype1diabetes AT knightjosh developmentofalifeexpectancytableforindividualswithtype1diabetes AT clarkephilipm developmentofalifeexpectancytableforindividualswithtype1diabetes AT svenssonannmarie developmentofalifeexpectancytableforindividualswithtype1diabetes AT eliassonbjorn developmentofalifeexpectancytableforindividualswithtype1diabetes AT palmerandrewj developmentofalifeexpectancytableforindividualswithtype1diabetes |